摘要
目的:探讨胸腔化疗联合中药治疗肺癌胸腔积液的临床效果。方法:选取2019年1月-2021年1月沈阳市第十人民医院肿瘤科收治的肺癌胸腔积液患者80例为观察对象,根据随机数字表法分为对照组与观察组,各40例。对照组给予胸腔引流与化疗方案治疗,观察组在对照组基础上联合中药外敷治疗,比较两组患者临床效果、不良反应发生率。结果:观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05);两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论:胸腔化疗联合中药治疗肺癌胸腔积液的临床效果较好,可明显降低患者不良反应发生率。
Objective:To explore the clinical effect of thoracic chemotherapy combined with traditional Chinese medicine in the treatment of pleural effusion in lung cancer.Methods:80 patients with pleural effusion of lung cancer admitted to the Department of Oncology,Shenyang Tenth People's Hospital from January 2019 to January 2021 were selected as observation subjects,and were divided into control group and observation group according to the random number table method,40 cases each.The control group was treated with thoracic drainage and chemotherapy program,and the observation group was treated with combined external application of traditional Chinese medicine on the basis of the control group.The clinical effects and incidence of adverse reactions of the two groups were compared.Results:The total efficiency of treatment in the observation group was higher than that in the control group,and the difference was statistically significant(P<0.05).There was no statistically significant difference between the incidence of adverse reactions in the two groups(P>0.05).Conclusion:The clinical effect of thoracic chemotherapy combined with traditional Chinese medicine in the treatment of pleural effusion of lung cancer is better,and the incidence of adverse reactions of patients can be significantly reduced.
作者
刘强
Liu Qiang(Department of Integrative Medicine and Oncology,Shenyang Tenth People's Hospital,Shenyang 110044,Liaoning Province,China)
出处
《中外医药研究》
2022年第11期90-92,共3页
JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH
关键词
肺癌胸腔积液
胸腔化疗
中药治疗
不良反应
Lung cancer pleural effusion
Thoracic chemotherapy
Traditional Chinese medicine treatment
Adverse reactions
